NewsBenzingaWells Fargo mantiene la recomendación de peso igual sobre aTyr Pharma y eleva el precio objetivo a 4 dólares. Wells Fargo mantiene la recomendación de peso igual sobre aTyr Pharma y eleva el precio objetivo a 4 dólares. Benzinga 2026.11.06 14:38 (GMT+0) Open on Benzinga Other news Keybanc Reiterates Sector Weight on NVIDIAto Sector Weight Top 3 Tech Stocks That May Fall Off A Cliff This Month Z Squared Secures 5-Yr Option To Acquire Nearly 90 Acres Near Arkansas Campus, Terms Undisclosed Truist Securities Maintains Hold on BILL Holdings, Raises Price Target to $66 Nvidia’s China Exit Could Trigger a Bull-Bear Showdown: 6 Leveraged ETFs to Watch Wednesday Truist Securities Downgrades Lucky Strike to Hold, Lowers Price Target to $4.35